Organigram Global Inc. · TSX:OGI
Organigram Global — Investor Presentation (June 2026)
19 slides from Organigram Global's investor presentation, June 2026
Slide 1: Investor Presentation
Investor Presentation June, 2026
Slide 2: Cautionary Statement
CAUTIONARY STATEMENT This document is current as of June 30, 2026, except where otherwise "financial outlook" within the meaning of applicable securities legislation. comparable. The most directly comparable measure to adjusted EBITDA stated. The information contained in this presentation is provide
Slide 3: Canadian Roots. Naturally Global.
Canadian Roots. Naturally Global. 13 YEARS OF WORLD CLASS INNOVATION GLOBAL RAPID RESPONSIBLE CAPABILITIES TRAILBLAZER STRATEGY INTERNATIONAL LEADERSHIP EXPANSION Founded in 2013, Organigram operates five Organigram is a leader In April 2026, Organigram Organigram exports Organigram transitioned adv
Slide 4: Canada's #1 LP in market
MILLED VAPES CONCENTRATES FLOWER Canada’s #1 #1 #1 #1 LP in market share1 PRE-ROLLS (including IPRs) FLOWER (including milled) EDIBLES RECREATIONAL MARKET #2 #2 #3 1. Multiple Sources (Hifyre, Weedcrawler, provincial boards, internal modelling) as of June 30, 2026.
Slide 5: Q3 Fiscal 2026 Highlights
Q3 Fiscal 2026 Highlights In millions unless otherwise indicated +49% +300 bps +136% $13.4 $105.8 37% 34% $70.8 $5.7 Q3 '25 Q3 '26 Q3 '25 Q3 '26 Q3 '25 Q3 '26 Net Revenue Adjusted Gross Margin1 Adjusted EBITDA1 Consolidation of Sanity Group Adjusted Gross Margin improved as Organigram’s record Adjus
Slide 6: State-of-the-art Facilities
State-of-the-art Facilities Canada’s largest indoor cultivation Winnipeg, MB Aylmer, ON London, ON Lac-Supérieur, QC Moncton, NB • Edibles facility with Advanced capabilities & • Centralized distribution hub to • Producing hang-dried, hand- • Three-tiered, modular, strain-specific automated cutting-
Slide 7: Moncton Spotlight: Canada's Largest Indoor Facility
Moncton Spotlight: Canada's Largest Indoor Facility Canada largest indoor cultivation 500,000 square-foot Each cultivation room In-house R&D labs Implementing automation facility with 144 modular grows vertically on three advancing genetic across production verticals and climate-controlled tiers, ma
Slide 8: Coast to Coast Canadian Leadership by Market Share
Coast to Coast Canadian Leadership by Market Share # 1 WESTERN CANADA # 1 EASTERN CANADA 1 # CENTRAL CANADA WINNIPEG MONCTON LAC SUPÉRIEUR LONDON & AYLMER Multiple Sources (Hifyre, Weedcrawler, provincial boards, internal modelling) as of June 30, 2026
Slide 9: Sanity Group Acquisition
Sanity Group Acquisition1 Organigram completed the acquisition of one of Germany's cannabis leaders, Sanity Group, in April 2026 to become the only pure-play cannabis company with leadership positions in the world's two largest federally legal markets, Canada and Germany. Sanity is a leading German
Slide 10: Expanding International Distribution
Expanding International Distribution • Through the acquisition of • Exporting medical whole flower Sanity Group, Organigram to multiple customers supplies medical flower to • Launched branded vape and Germany, the UK, Czechia and edibles sales in Q2 Fiscal 2026 Poland, and operates two recreational
Slide 11: Portfolio of Brands
Portfolio of Brands Delivering strong coverage across all segments and categories — now expanding into Europe with the Sanity portfolio. New PREMIUM REC New New New MAINSTREAM Vayamed avaay MED REC CBD MED New New VALUE MED MED Flower Milled Pre-Rolls Infused Pre-Rolls Vapes Beverages Edibles Hash C
Slide 12: Award-winning mainstream brand
• Award-winning mainstream brand • #1 concentrates and #2 Canadian vape Premium • • #2 innovation flower brand brand1 in Canada • Now leveraging FAST nanoemulsion brand by market share1 First Organigram • • Focused brand tocatering on larger formats launch to technology for some ingestible products
Slide 13: Strategic Partnership with BAT
Strategic Partnership with BAT: 2026 2024 2021 $221 Million $125 Million $65 Million • Established the PDC with formation of a • Creation of strategic investment pool • Financing provided to support acquisition of Center of Excellence at Moncton campus named Jupiter, funded with $83.1 million Sanity
Slide 14: Q3 F'26 Revenue and Margins
Q3 F'26 Revenue and Margins 38% 38% 37% 34% 33% 33% 31% $145.1 $123.3 $110.2 $97.3 $93.3 $102.8 $66.8 $105.8 $80.1 $65.6 $70.8 $63.5 $59.8 $42.7 $39.1 $30.6 $23.9 $14.3 $21.9 $24.2 $18.4 Q1 F25 Q2 F25 Q3 F25 Q4 F25 Q1 F26 Q2 F26 Q3 F26 In millions 1 1 Net Revenue Gross Revenue Adj. Gross Margin Adj.
Slide 15: Q3 F'26 Adjusted EBITDA
Q3 F'26 Adjusted EBITDA1 $13.4 $9.8 $5.7 $5.3 $4.9 $1.4 $0.9 Q1 F25 Q2 F25 Q3 F25 Q4 F25 Q1 F26 Q2 F26 Q3 F26 In millions 1. Adjusted EBITDA is a non-IFRS financial measures not defined by and does not have any standardized meanings under IFRS, as issued by the International Accounting Standards Boa
Slide 16: Balance Sheet
Balance Sheet Q3 Fiscal 2026: $11.7 million $49.2 million Total cash Total liquidity1 1 Inclusive of debt facilities
Slide 17: Q3 FY26 Select Financial Metrics
Q3 FY26 Select Financial Metrics In 000’s unless otherwise indicated Select Key Financial Metrics (in $000s unless otherwise indicated) Q3-2026 Q3-2025 % Change Gross revenue 145,071 110,205 32% Excise taxes (39,289) (39,413) nm Net revenue 105,782 70,792 49% Cost of sales 66,980 48,369 38% Gross ma
Slide 18: Q3 FY26 Select Balance Sheet Metrics
Q3 FY26 Select Balance Sheet Metrics In 000’s unless otherwise indicated Select Balance Sheet Metrics (in $000s) June 30, 2026 September 30, 2025 % Change Cash & short-term investments (including restricted cash) 11,667 84,420 (86)% Biological assets & inventories 165,056 123,954 33% Other current a
Slide 19: Capital Structure
Capital Structure In 000’s unless otherwise indicated Capital Structure June 30, 2026 August 7, 2026 Common shares issued and outstanding 140,975 141,007 Preferred shares1 49,204 49,204 Options (Weighted Average Exercise Price: $8.14) 2,686 2,677 Warrants (Exercise Price: $3.65) 4,451 4,451 Top-up r
Organigram Global — Investor Presentation (June 2026) on 6ix